UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported) August 6, 2012

 

 

 

FUSE SCIENCE, INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Nevada

(State or Other Jurisdiction

of Incorporation)

 

     
000-22991   87-0460247
(Commission
File Number)
  (IRS Employer
Identification No.)
   
6135 NW 167th Street, #E-21
Miami Lakes, Florida
  33015
(Address of Principal Executive Offices)   (Zip Code)

 

(305) 503-3873

(Registrant’s telephone number, Including Area Code)

 

 

 

Check the appropriate box if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 7.01 Regulation FD Disclosure

 

On August 6, 2012 Fuse Science, Inc. held a business update teleconference for shareholders and members of the investment community. A replay of the teleconference will be available until August 20th, 2012 which can be accessed by dialing (877) 660-6853 if calling within the United States or (201) 612-7415, if calling internationally. Please enter account #286 and conference ID #398685 to access the replay. A replay of the webcast will also be archived and available within the investor relations section of the Company’s web site at www.fusescience.com.

 

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  FUSE SCIENCE, INC.
     
  /s/ Brian Tuffin
  Name: Brian Tuffin
  Title: Chief Executive Officer and Chief Financial Officer 

 

Dated: August 7, 2012